Valuation: LifeVantage Corporation

Market Cap 82M 70.34M 65.68M 60.26M 113M 7.84B 115M 775M 303M 3.93B 308M 301M 13B P/E 2026 *
15.5x
P/E 2027 * 16.7x
Enterprise Value 68.45M 58.72M 54.83M 50.31M 94.6M 6.54B 96.16M 647M 253M 3.28B 257M 251M 10.85B EV / Sales 2026 *
0.37x
EV / Sales 2027 * 0.38x
Free-Float
85.52%
Yield 2026 *
-
Yield 2027 * -
1 day+2.04%
1 week-0.15%
Current month+1.09%
1 month+4.84%
3 months+23.57%
6 months+28.46%
Current year+5.52%
1 week 6.36
Extreme 6.36
6.69
1 month 6.18
Extreme 6.18
6.97
Current year 3.9
Extreme 3.9
11.71
1 year 3.9
Extreme 3.9
14.28
3 years 3.9
Extreme 3.9
27.38
5 years 3.04
Extreme 3.04
27.38
10 years 2.86
Extreme 2.86
27.38
Manager TitleAgeSince
Chief Executive Officer 63 04/08/2026
Director of Finance/CFO 53 24/10/2021
Chief Tech/Sci/R&D Officer - 06/01/2026
Director TitleAgeSince
Director/Board Member 67 31/01/2017
Director/Board Member 68 16/02/2022
Chairman 63 26/11/2023
Date Insider Type Main position Quantity % Market Cap.
06/08/26 Free

Chief Executive Officer

848,765 6.7278%
01/07/26 Tax

Chief Financial Officer

-1,361 0.0108%
01/07/26 Tax

Responsable ventes & marketing

-1,717 0.0136%
Change 5-day change 1-year change 3-year change Capi.($)
+2.04%-0.15%-50.34%+24.76% 82M
+4.46%+4.92%+82.07%+134.31% 1,141B
+0.85%+4.81%+53.77%+58.51% 659B
+2.72%+6.92%+28.99%+77.15% 470B
+0.29%+1.60%+40.28%+44.75% 366B
+0.34%+3.17%+24.72%+41.84% 302B
+0.32%+3.48%+1.16%+13.50% 254B
+4.02%+6.29%+49.67%+68.96% 239B
-0.22%-0.27%-13.93%-52.83% 207B
+2.90%+8.63%+25.11%+94.52% 183B
Average +1.40%+3.68%+24.15%+50.55% 382.11B
Weighted average by Cap. +1.13%+4.31%+46.80%+74.17%

Financials

2026 *2027 *
Net sales 184M 158M 148M 135M 255M 17.6B 259M 1.74B 682M 8.83B 692M 677M 29.19B 178M 153M 143M 131M 246M 17.05B 251M 1.69B 660M 8.55B 670M 655M 28.27B
Net income 5.3M 4.55M 4.25M 3.89M 7.32M 507M 7.44M 50.09M 19.62M 254M 19.9M 19.47M 840M 4.9M 4.2M 3.92M 3.6M 6.77M 468M 6.88M 46.31M 18.13M 235M 18.4M 18M 777M
Net Debt -13.55M -11.62M -10.85M -9.96M -18.73M -1.3B -19.03M -128M -50.15M -650M -50.88M -49.77M -2.15B -15M -12.86M -12.01M -11.02M -20.72M -1.43B -21.06M -142M -55.5M -719M -56.3M -55.08M -2.38B
Logo LifeVantage Corporation
LifeVantage Corporation is an activation company, which is engage in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, weight management products, pre- and pro-biotics, skin and hair care products, and nootropics. The Company’s line of scientifically validated activators includes the flagship Protandim family of products, TrueScience Liquid Collagen, the newest MindBody GLP-1 System, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System , as well as AXIO nootropic energy drink mixes, the full TrueScience line of skin and hair care products, and Petandim, a pet supplement formulated to combat oxidative stress in dogs. It sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand and Singapore.
Employees
235
Date Price Change Volume
19/08/26 US$6.500 +2.04% 52,344
18/08/26 US$6.370 -2.30% 31,767
17/08/26 US$6.520 -0.76% 42,259
14/08/26 US$6.570 +1.23% 44,291
13/08/26 US$6.490 -0.31% 40,322
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
6.500USD
Average target price
7.000USD
Spread / Average Target
+7.69%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LFVN Stock